What is the dose of Faropenem (antibiotic)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: April 13, 2025 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

From the Research

Faropenem dosing should be 15 mg/kg/day, divided into three doses, for pediatric patients, as this regimen has been shown to be effective and safe in treating various bacterial infections, including upper respiratory tract infections, urinary tract infections, and dermatological infections, as demonstrated in a study published in 2022 1. The dosing of faropenem may vary depending on the patient's age, weight, and renal function.

  • For adult patients with normal renal function, a dose of 200 mg twice daily has been suggested, as shown in a study published in 2017 2.
  • However, for patients with impaired renal function, the dose may need to be adjusted to avoid accumulation of the drug and potential toxicity.
  • It is essential to note that faropenem is a carbapenem antibiotic, and its use should be guided by local antimicrobial resistance patterns and susceptibility testing.
  • The safety and efficacy of faropenem have been demonstrated in several studies, including a study published in 2008, which showed that the drug was effective in treating bacterial infectious diseases in pediatric patients, with a low incidence of adverse reactions 3.
  • In general, the dosing of carbapenem antibiotics, including faropenem, should be individualized based on the patient's specific needs and clinical circumstances, as highlighted in a review published in 2000 4.

References

Research

Dialyzability of Faropenem in Infected Patients on Chronic Hemodialysis.

Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.